Structure-Based Virtual Screening Accelerates GPCR Drug Discovery
- PMID: 32340753
- DOI: 10.1016/j.tips.2020.04.001
Structure-Based Virtual Screening Accelerates GPCR Drug Discovery
Abstract
Virtual ligand screening (VLS) against high-resolution structures of G-protein-coupled receptors (GPCRs) is likely to become the next-generation drug design approach of choice. Stein and colleagues recently demonstrated the feasibility of such an approach by discovering novel chemical scaffolds for the melatonin MT1 receptor and compounds with unique in vivo activities.
Keywords: G-protein-coupled receptor; circadian rhythm; melatonin; melatonin receptor.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment on
-
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.Nature. 2020 Mar;579(7800):609-614. doi: 10.1038/s41586-020-2027-0. Epub 2020 Feb 10. Nature. 2020. PMID: 32040955 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
